Antiphospholipid antibodies as non-traditional risk factors in atherosclerosis based cardiovascular diseases without overt autoimmunity. A critical updated review
… was that aPL are a risk factor for incident stroke and that … risk factor for incident IS and two
Class I studies that did not. Seven Class II studies supported aPL as an independent risk factor …
Class I studies that did not. Seven Class II studies supported aPL as an independent risk factor …
Traditional and non traditional risk factors in accelerated atherosclerosis in systemic lupus erythematosus: role of vascular endothelial growth factor (VEGATS Study)
BM Colombo, F Cacciapaglia, M Puntoni… - Autoimmunity …, 2009 - Elsevier
… such as homocysteine, protein C and fibrinogen were in the normal range, even if higher as
compared with controls, whereas CRP, antiphospholipid antibodies and lupus anticoagulant …
compared with controls, whereas CRP, antiphospholipid antibodies and lupus anticoagulant …
Cardiovascular disease in the antiphospholipid syndrome
J Amaya-Amaya, A Rojas-Villarraga, JM Anaya - Lupus, 2014 - journals.sagepub.com
… Interestingly, the excessive CV events observed in patients with APS are not fully
explained by these factors. In recent years, several novel non-traditional risk factors for the …
explained by these factors. In recent years, several novel non-traditional risk factors for the …
16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome
… ; b) the current knowledge on non-traditional manifestations associated with aPL; and c)
the … of aPL as diagnostic antibodies to considering them to be risk factors for clinical events. …
the … of aPL as diagnostic antibodies to considering them to be risk factors for clinical events. …
Non-traditional risk factors for atherosclerotic disease: A review for emergency physicians
… A positive antiphospholipid antibody titer has been identified as being associated with
CVD related-mortality [6]. It is believed that the chronic inflammation may accelerate the …
CVD related-mortality [6]. It is believed that the chronic inflammation may accelerate the …
Antiphospholipid antibodies disappearance in primary antiphospholipid syndrome: thrombosis recurrence
G Medina, E Briones-García, MP Cruz-Domínguez… - Autoimmunity …, 2017 - Elsevier
… antiphospholipid antibodies (aPL) (lupus anticoagulant (LA), and/or anticardiolipin (aCL) and
anti-β2-glycoprotein 1 antibodies … syndrome is a constellation of cardiovascular risk factors, …
anti-β2-glycoprotein 1 antibodies … syndrome is a constellation of cardiovascular risk factors, …
Patients with primary antiphospholipid antibody syndrome and without associated vascular risk factors present a normal endothelial function
P Gresele, R Migliacci, MC Vedovati, A Ruffatti… - Thrombosis research, 2009 - Elsevier
… antiphospholipid antibody syndrome (PAPS) is characterized by venous or arterial thrombosis
and positive antiphospholipid antibodies. … PAPS and no associated risk factors with that of …
and positive antiphospholipid antibodies. … PAPS and no associated risk factors with that of …
Additional risk factors associated with thrombosis and pregnancy morbidity in a unique cohort of antiphospholipid antibody-positive patients
C Li, Y Zuo, S Zhang, UE Makris, DR Karp… - Chinese medical …, 2022 - mednexus.org
… risks of arterial thrombosis, venous thrombosis, and pregnancy morbidities in a large cohort
of persistent antiphospholipid antibodies … Non-traditional APS risk factors, new biomarkers (ie…
of persistent antiphospholipid antibodies … Non-traditional APS risk factors, new biomarkers (ie…
Current treatment strategies for management of antiphospholipid syndrome
R Reggia, L Andreoli, A Tincani… - Expert Opinion on …, 2014 - Taylor & Francis
… Hence, the search for additional risk factors is needed in the critical analysis of the individual
clinical setting in order to optimize the therapy. Third, a not negligible (notable) proportion …
clinical setting in order to optimize the therapy. Third, a not negligible (notable) proportion …
[HTML][HTML] The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus
… Independent of aPL, because of the increased incidence of traditional cardiovascular
disease (CVD) and non-traditional lupus-related risk factors, eg, inflammation, renal disease, or …
disease (CVD) and non-traditional lupus-related risk factors, eg, inflammation, renal disease, or …
相关搜索
- non-traditional risk factors critical updated review
- thrombotic risk factor antiphospholipid antibodies
- traditional risk factor assessment
- traditional risk factors accelerated atherosclerosis
- systemic lupus erythematosus antiphospholipid antibodies
- antiphospholipid syndrome cardiac manifestations
- patients with primary antiphospholipid syndrome
- antiphospholipid syndrome prospective analysis
- antiphospholipid syndrome clinical manifestations
- antiphospholipid syndrome cardiovascular disease
- meta analysis antiphospholipid antibodies
- non-traditional risk factors overt autoimmunity
- non-traditional risk factors cardiovascular diseases
- non-traditional risk factors emergency physicians
- traditional risk factors systemic lupus erythematosus
- clinical significance of antiphospholipid antibodies